Specifically, thiobarbituric acid–reactive substances (TBARS) and protein carbonyl content (PCC) levels have been reported significantly higher in patients with schizophrenia than in controls, with no differences in total reactive antioxidant potential (TRAP) and TNF-α levels among patients at early and late stages. The gene discussed is TNF; the disease is schizophrenia.